The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib
Wendy T Parker(University of South Australia), Susan Branford(Centre for Cancer Biology), Chani Field(South Australia Pathology), Haley Altamura(South Australia Pathology), John Hodgson(University of California, San Francisco), Victor M. Rivera(Ariadne Diagnostics (United States)), Timothy P. Hughes(South Australia Pathology), Bronte A. Jamison(South Australia Pathology), David T Yeung(South Australia Pathology), Alexandra L. Yeoman(South Australia Pathology), Stephanie Lustgarten(Ariadne Diagnostics (United States))
Cited by 65
Related Papers
New handbook for standardised measurement of plant functional traits worldwide
|Australian Journal of Botany|2013|4.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
|BMC Medicine|2008|948
<i>Corrigendum to</i> : New handbook for standardised measurement of plant functional traits worldwide
|Australian Journal of Botany|2016|723